Anticonvulsants Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Anticonvulsants Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Anticonvulsants Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Epilepsy
- 1.3.3 Fibromyalgia
- 1.3.4 Migraine
- 1.3.5 Neuropathic pain
- 1.3.6 Bipolar disorder
- 1.3.7 Anxiety
- 1.3.8 Borderline personality disorder
1.4 Market Segment by Application
- 1.4.1 Global Anticonvulsants Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Home Care
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Anticonvulsants Market Size
- 2.1.1 Global Anticonvulsants Revenue 2014-2025
- 2.1.2 Global Anticonvulsants Sales 2014-2025
2.2 Anticonvulsants Growth Rate by Regions
- 2.2.1 Global Anticonvulsants Sales by Regions 2014-2019
- 2.2.2 Global Anticonvulsants Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Anticonvulsants Sales by Manufacturers
- 3.1.1 Anticonvulsants Sales by Manufacturers 2014-2019
- 3.1.2 Anticonvulsants Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Anticonvulsants Revenue by Manufacturers (2014-2019)
- 3.2.2 Anticonvulsants Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anticonvulsants Market Concentration Ratio (CR5 and HHI)
3.3 Anticonvulsants Price by Manufacturers
3.4 Key Manufacturers Anticonvulsants Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anticonvulsants Market
3.6 Key Manufacturers Anticonvulsants Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Epilepsy Sales and Revenue (2014-2019)
- 4.1.2 Fibromyalgia Sales and Revenue (2014-2019)
- 4.1.3 Migraine Sales and Revenue (2014-2019)
- 4.1.4 Neuropathic pain Sales and Revenue (2014-2019)
- 4.1.5 Bipolar disorder Sales and Revenue (2014-2019)
- 4.1.6 Anxiety Sales and Revenue (2014-2019)
- 4.1.7 Borderline personality disorder Sales and Revenue (2014-2019)
4.2 Global Anticonvulsants Sales Market Share by Type
4.3 Global Anticonvulsants Revenue Market Share by Type
4.4 Anticonvulsants Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Anticonvulsants Sales by Application

6 United States

6.1 United States Anticonvulsants Breakdown Data by Company
6.2 United States Anticonvulsants Breakdown Data by Type
6.3 United States Anticonvulsants Breakdown Data by Application

7 European Union

7.1 European Union Anticonvulsants Breakdown Data by Company
7.2 European Union Anticonvulsants Breakdown Data by Type
7.3 European Union Anticonvulsants Breakdown Data by Application

8 China

8.1 China Anticonvulsants Breakdown Data by Company
8.2 China Anticonvulsants Breakdown Data by Type
8.3 China Anticonvulsants Breakdown Data by Application

9 Rest of World

9.1 Rest of World Anticonvulsants Breakdown Data by Company
9.2 Rest of World Anticonvulsants Breakdown Data by Type
9.3 Rest of World Anticonvulsants Breakdown Data by Application
9.4 Rest of World Anticonvulsants Breakdown Data by Countries
- 9.4.1 Rest of World Anticonvulsants Sales by Countries
- 9.4.2 Rest of World Anticonvulsants Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Anticonvulsants Sales Channels
- 11.2.2 Anticonvulsants Distributors
11.3 Anticonvulsants Customers

12 Market Forecast

12.1 Global Anticonvulsants Sales and Revenue Forecast 2019-2025
12.2 Global Anticonvulsants Sales Forecast by Type
12.3 Global Anticonvulsants Sales Forecast by Application
12.4 Anticonvulsants Forecast by Regions
- 12.4.1 Global Anticonvulsants Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anticonvulsants Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

The Anticonvulsants are the diverse group of the pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder. They seem to act as mood stabilizers, and for the treatment of neuropathic pain. Anticonvulsants suppress the rapid and excessive firing of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain.
Anticonvulsant drugs are primarily developed for the treatment of epilepsy, a neurological condition that affects around the 50 million people worldwide. They reduce seizure frequency by suppressing neuronal excitability via various molecular targets in the synapse, including voltage-gated ion channels, voltage-gated GABAA (γ-aminobutyric acid type A) receptors and glutamate receptors.
In 2019, the market size of Anticonvulsants is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anticonvulsants.

This report studies the global market size of Anticonvulsants, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anticonvulsants sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Johnson & Johnson (J&J)
Novartis AG
UCB Group
GlaxoSmithKline plc.
Pfizer Inc.
Abbott Laboratories
Cephalon Inc.
Shire plc.

Market Segment by Product Type
Epilepsy
Fibromyalgia
Migraine
Neuropathic pain
Bipolar disorder
Anxiety
Borderline personality disorder

Market Segment by Application
Hospital
Clinic
Home Care

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anticonvulsants status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anticonvulsants manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anticonvulsants are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025